GLP-1 side effects on TikTok: what's real vs. what's overblown

What did @my.journey.with.marc actually say?

Mark's claim is straightforward: significant fat loss on tirzepatide (Mounjaro) changes the appearance of the genital area, not because anatomy changes, but because surrounding fat disappears. For men, he says things can "appear different or bigger" due to less pubic fat. For women, he references skin changes and shape shifts in that region. He also nods toward "tightening treatments" becoming a conversation in post-transformation communities.

To be fair, this is a genuinely underreported topic. Mark isn't claiming a drug effect on genitalia itself. He's describing a mechanical, fat-loss consequence that applies to anyone losing large amounts of weight quickly, whether from GLP-1 drugs, bariatric surgery, or any other method. He's careful not to overclaim, and the framing is personal experience plus anecdote from his audience. That's not nothing, but it's also not science.

Does the science back this up?

Yes, the basic anatomy here is real, and the research on rapid weight loss body changes supports it. The phenomenon Mark is describing in men has a clinical name: buried or concealed penis, which is associated with a large pubic fat pad. Fat loss in that region can meaningfully change penile appearance without any structural change to the penis itself.

A 2019 paper by Alter et al. in the Journal of Urology documented this effect in men undergoing bariatric surgery, noting visible changes to penile length perception after significant fat loss. For women, the mons pubis and labia majora contain adipose tissue, and rapid fat redistribution can alter their appearance and skin laxity. The broader skin laxity issue following rapid GLP-1-driven weight loss is documented: a 2023 review by Wilding et al. in Diabetes, Obesity and Metabolism noted loose skin as a common patient-reported outcome after tirzepatide-driven loss exceeding 15% body weight. Mark lost roughly 22% of body weight in under a year, which puts him squarely in the range where these changes are expected.

What did they get wrong (or right)?

He got the core mechanism right. He got the framing mostly right. What he got wrong, or at least muddy, is specificity. He blends male and female experiences in a way that sounds symmetrical when the physiology is quite different. For men, the change is primarily a fat pad reduction. For women, hormonal shifts from rapid weight loss can also affect tissue in that region, something he doesn't mention at all.

There's also a product plug woven in for "Elastic Skin," a brand he promotes. He doesn't disclose whether this is a paid partnership, and the implication that a topical product addresses skin changes in intimate areas after major weight loss is not backed by robust evidence. Topical treatments for skin laxity after massive weight loss have limited clinical support. The American Society of Plastic Surgeons notes that surgical intervention is typically the only effective option for significant excess skin. Recommending a skincare brand without that context is a gap in honesty, if not an outright error.

What should you actually know?

If you're losing substantial weight on a GLP-1 drug, body composition changes in the pubic and genital region are real and documented. They're not a drug side effect in the pharmacological sense; tirzepatide is not acting on genital tissue. This is mechanical fat loss, the same thing that happens with any significant weight reduction.

What is worth knowing: the speed of GLP-1-driven weight loss is faster than most traditional interventions, which means skin adaptation has less time to keep up. A 2022 trial by Jastreboff et al. in the New England Journal of Medicine showed tirzepatide producing up to 22.5% body weight reduction over 72 weeks. That pace can outstrip skin elasticity. If you're noticing changes in how your body looks in private areas, that is normal, documented, and not a sign something went wrong medically. It may, however, be worth discussing skin concerns with a dermatologist or plastic surgeon rather than relying on influencer-recommended topicals.

• Talk to your prescribing clinician if body changes are causing distress, physical or psychological.
• Be skeptical of product endorsements embedded in medical content, especially without clear disclosure of commercial relationships.
• Skin laxity after rapid weight loss is a known, documented outcome, not a fringe experience.